Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer

被引:0
|
作者
He, Wenfeng [1 ]
Zhang, Jingheng [2 ]
Wen, Siyuan [3 ]
Li, Ying [3 ]
Shen, Lin [3 ]
Zhou, Tiejun [4 ]
Wen, Qinglian [1 ]
Fan, Yu [1 ]
机构
[1] Southwest Med Univ, Dept Oncol, Affiliated Hosp, Luzhou 646000, Peoples R China
[2] Peoples Hosp Luzhou, Dept Oncol, Luzhou 646000, Peoples R China
[3] Southwest Med Univ, Fac Clin Med, Luzhou 646000, Peoples R China
[4] Southwest Med Univ, Dept Pathol, Affiliated Hosp, Luzhou 646000, Peoples R China
关键词
breast cancer; cell adhesion molecule; DNA methylation; immune microenvironment; LTBP4; tumor suppressor; BETA-BINDING-PROTEIN; LATENT-TGF-BETA; EXTRACELLULAR-MATRIX; BINDING-PROTEIN-4; LTBP-4; MULTIPLE; METHYLATION; DISRUPTION; EXPRESSION; TGF-BETA-1; SURVIVAL;
D O I
10.1080/17501911.2024.2388017
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: To explore the LTBP4's expression, prognostic significance and molecular mechanism of action in breast cancer (BC). Methods: On the basis of omics datasets and experiments, we conducted a synthetical analysis of LTBP4 in BC. Results & conclusion: LTBP4 was downregulated in BC with high promoter methylation and low genetic alteration. DNA methylation was negatively associated with LTBP4 mRNA expression. Higher LTBP4 associated with better survival. LTBP4 was enrichment in extracellular matrix receptor interactions, cell adhesion molecules, cell cycle and MAPK pathway. LTBP4 expression and methylation were positively and negatively associated with tumor infiltrating immune cells, respectively. In conclusion, LTBP4 is a putative tumor suppressor in BC, which expression is regulated by DNA methylation and relates with prognosis.
引用
收藏
页码:999 / 1012
页数:14
相关论文
共 50 条
  • [32] The Role of Adenosine Monophosphate-Activated Kinase α2 as a Putative Tumor Suppressor in Breast Cancer
    Fox, M. M.
    Phoenix, K. N.
    Vumbaca, F.
    Vernier, K. M.
    Claffey, K. P.
    CANCER RESEARCH, 2009, 69 (24) : 697S - 697S
  • [33] Epigenetic silencing of tumor suppressor genes in pancreatic cancer
    Lomberk G.A.
    Journal of Gastrointestinal Cancer, 2011, 42 (2) : 93 - 99
  • [34] Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer
    Versmold, Beatrix
    Felsberg, Joerg
    Mikeska, Thomas
    Ehrentraut, Denise
    Koehler, Juliane
    Hampl, Juergen A.
    Roehn, Gabriele
    Niederacher, Dieter
    Betz, Beate
    Hellmich, Martin
    Pietsch, Torsten
    Schmutzler, Rita K.
    Waha, Andreas
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 547 - 554
  • [35] Tumor suppressor genes and breast cancer
    Buchholz, TA
    Weil, MM
    Story, MD
    Strom, EA
    Brock, WA
    McNeese, MD
    RADIATION ONCOLOGY INVESTIGATIONS, 1999, 7 (02): : 55 - 65
  • [36] GCIP Is a Tumor Suppressor in Breast Cancer
    Chang, T-W
    Chang, M-C
    CANCER RESEARCH, 2009, 69 (24) : 698S - 698S
  • [37] Tumor suppressor genes in breast cancer
    Oesterreich, S
    Fuqua, SAW
    ENDOCRINE-RELATED CANCER, 1999, 6 (03) : 405 - 419
  • [38] Identification of Fat4 as a candidate tumor suppressor gene in breast cancers
    Qi, Chao
    Zhu, Yiwei Tony
    Hu, Liping
    Zhu, Yi-Jun
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 793 - 798
  • [39] Identification of New Tumor Suppressor Genes in Triple-Negative Breast Cancer
    Rangel, Roberto
    Guzman-Rojas, Liliana
    Kodama, Takahiro
    Kodama, Michiko
    Newberg, Justin Y.
    Copeland, Neal G.
    Jenkins, Nancy A.
    CANCER RESEARCH, 2017, 77 (15) : 4089 - 4101
  • [40] Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors
    Kempkensteffen, Carsten
    Christoph, Frank
    Weikert, Steffen
    Krause, Hans
    Koellermann, Jens
    Schostak, Martin
    Miller, Kurt
    Schrader, Mark
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (12) : 765 - 770